OraLiva, Inc. has been awarded a prestigious Direct to Phase II SBIR grant from the National Institute of Dental and Craniofacial Research (NIDCR) at the National Institutes of Health (NIH). This funding supports the continued development of our groundbreaking AI-linked cytomics-on-a-chip platform.
OraLiva was recently featured on the Slice of Healthcare podcast. In this episode, Denise Marks of the CareQuest Institute of Oral Health and Dr. John T. McDevitt, founder of OraLiva, joined the discussion to share perspectives on advancing innovation in oral health diagnostics.
OraLiva was recently highlighted by CareQuest Innovation Partners in their SMILE Health program case study. The feature outlines how OraLiva’s AI-powered brush biopsy is addressing the challenge of late oral cancer detection by bringing lab-quality cytology into the dental chair.
OraLiva was recently featured in Becker’s Dental + DSO Review in an article by Cameron Cortigiano. The piece highlights the urgent need for improved oral cancer screening technology and how OraLiva is working to close that gap.
